Ingrezza 40 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FQ1UZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,676
Award facts
- Contract value 100% obligated
- $3,676.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Ingrezza 40 mg capsules (30-count) valued at $3,676.12 with a firm fixed price structure. This non-set-aside competitive award is classified as a delivery order with an ultimate completion date of August 7, 2025, and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ingrezza is a prescription medication used to treat involuntary movements associated with tardive dyskinesia, representing the type of specialty pharmaceutical products that fall within AmerisourceBergen's federal procurement portfolio.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The contract encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains, positioning AmerisourceBergen as a key vendor for federal medical supply needs.
Quick answers
Who was awarded contract SPE2DB25FQ1UZ?
SPE2DB25FQ1UZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 17, 2025.
How much is contract SPE2DB25FQ1UZ worth?
The government has obligated $3,676 on SPE2DB25FQ1UZ.
Is contract SPE2DB25FQ1UZ an order under another contract?
Yes. SPE2DB25FQ1UZ is a delivery order under SPE2DB22D3011, an indefinite delivery contract.
Was contract SPE2DB25FQ1UZ competed?
The extent of competition for SPE2DB25FQ1UZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award